Please use this identifier to cite or link to this item: https://doi.org/10.1111/j.1365-2222.2012.04025.x
DC FieldValue
dc.titleQuality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States
dc.contributor.authorMaspero, J.
dc.contributor.authorLee, B.W.
dc.contributor.authorKatelaris, C.H.
dc.contributor.authorPotter, P.C.
dc.contributor.authorCingi, C.
dc.contributor.authorLopatin, A.
dc.contributor.authorSaffer, M.
dc.contributor.authorNadeau, G.
dc.contributor.authorWalters, R.D.
dc.date.accessioned2016-07-10T02:36:38Z
dc.date.available2016-07-10T02:36:38Z
dc.date.issued2012-12
dc.identifier.citationMaspero, J., Lee, B.W., Katelaris, C.H., Potter, P.C., Cingi, C., Lopatin, A., Saffer, M., Nadeau, G., Walters, R.D. (2012-12). Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States. Clinical and Experimental Allergy 42 (12) : 1684-1696. ScholarBank@NUS Repository. https://doi.org/10.1111/j.1365-2222.2012.04025.x
dc.identifier.issn09547894
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/125883
dc.description.abstractThere is comparatively little information on health-related quality of life (HRQoL) in subjects with allergic rhinitis (AR) or allergic rhinoconjunctivitis (AR/C) in countries beyond western Europe and North America. The primary aim of this investigation was therefore to review and assess the information in the public domain on HRQoL in AR/C patients from diverse regions of the world, represented by different countries, including Argentina, Australia, Brazil, Russia, Singapore, South Africa and Turkey. Second, in view of the absence of a standardized definition for 'AR control', the review aimed to determine whether a working definition of AR/C can be inferred from validated tests or other instruments documented to date. Despite the comparatively low number of studies, this review demonstrated that overall the symptoms of AR/C impair the HRQoL of patients in these regions by adversely impacting sleep, daily activities, physical and mental status and social functioning, similar to that demonstrated in much larger numbers of studies of AR/C patients in Europe and the United States. Furthermore, the findings of the review suggest that 'overall' control of the disease should encompass reduction of nasal and ocular symptoms, as well as improvements in HRQoL, comorbid conditions and cognition. Although some instruments are currently available for measuring control of AR, none are capable of assessing all these aspects, emphasizing the need to develop appropriate new instruments. © 2012 Blackwell Publishing Ltd.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1111/j.1365-2222.2012.04025.x
dc.sourceScopus
dc.subjectAllergic rhinitis
dc.subjectAllergic rhinoconjunctivitis
dc.subjectControl
dc.subjectDiverse regions
dc.subjectHealth-related quality of life
dc.typeReview
dc.contributor.departmentPAEDIATRICS
dc.description.doi10.1111/j.1365-2222.2012.04025.x
dc.description.sourcetitleClinical and Experimental Allergy
dc.description.volume42
dc.description.issue12
dc.description.page1684-1696
dc.description.codenCLEAE
dc.identifier.isiut000311612300004
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

23
checked on Oct 19, 2021

WEB OF SCIENCETM
Citations

25
checked on Oct 19, 2021

Page view(s)

80
checked on Oct 14, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.